Summary
Boston Scientific Corporation (BSX) has filed an 8-K report on July 27, 2021, to announce its financial results for the second quarter ended June 30, 2021. The primary purpose of this filing is to furnish the press release detailing these results, which is attached as Exhibit 99.1. Investors should refer to this press release for specific financial performance figures, including revenue, earnings, and other key operational metrics for the quarter. While the 8-K itself is brief and primarily serves as a notification of the press release, the attached document contains the substance of the company's performance. This includes the financial condition and results of operations for the period. It is important to note that the information furnished in this Item 2.02 and Exhibit 99.1 is not considered 'filed' for the purposes of Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities as other filed information, nor is it automatically incorporated by reference into other filings.
Key Highlights
- 1BSX announced its Q2 2021 financial results via a press release furnished with the 8-K filing.
- 2The press release (Exhibit 99.1) contains detailed information on the company's financial condition and results of operations for the quarter ended June 30, 2021.
- 3Investors should consult the furnished press release for specific performance metrics, revenue, and earnings data.
- 4The filing does not contain new material financial statements beyond what is presented in the press release.
- 5Information in Item 2.02 and Exhibit 99.1 is furnished, not filed, and therefore does not subject the company to Section 18 liabilities of the Exchange Act.
- 6The 8-K also includes the Cover Page Interactive Data File (XBRL) for enhanced data access.